-1.png?width=300&height=58&name=Proscia%20(11)-1.png "Proscia")
FREE RESOURCE FOR PATHOLOGY LEADERS
The Strategic Buyer's Guide to
Evaluating Digital Pathology Platforms
Built from hundreds of RFPs at leading health systems and diagnostic labs—so you don't have to start from scratch. 200+ requirements. Security and compliance checklist. LIS integrations requirements. Evaluation scorecards.
Selecting a digital pathology platform is one of the most consequential technology decisions a lab can make.
This Buyer's Guide helps selection committees with an evidence-based framework to evaluate every critical dimension with clarity and confidence. It supports teams at any stage–from early evaluation to vendor demos, by driving fast alignment and preventing requirements gaps that often surface after a contract is signed. This is especially critical for healthcare organizations assessing enterprise digital pathology platforms across pathology, IT, operations, procurement, and finance.
Complete Requirements Checklist
200+ vetted requirements across clinical, technical, security, and integration categories.
Evaluation Scoring Templates
Weighted scoring frameworks that help your selection committee objectively compare vendors and reach consensus.
LIS Integration Checklists
Production-proven requirements for Epic Beaker, Cerner PathNet, and multi-vendor environments.
Security & Compliance Requirements
SOC 2 Type II, ISO 27001, HIPAA, and cloud security requirements ready to include.
Pathologist-First Design Criteria
Workflow efficiency benchmarks, ergonomic requirements, and adoption-focused evaluation criteria.
Download the Buyer's Guide
Ready To Go Digital?
Many labs and pathology groups adopt digital pathology without a lengthy procurement cycle. If that fits your situation, we offer a streamlined path so you can move forward in weeks, not months.
Proscia is rewiring pathology for precision medicine to improve patient outcomes. Its technology fuels the development and use of novel therapies and diagnostics, harnessing data and AI in the fight against humanity’s most challenging diseases, like cancer. 16 of the top 20 pharmaceutical companies rely on these solutions each day, and Proscia was named Global 2026 Best in KLAS for Digital Pathology in Europe. For more information, visit proscia.com and follow Proscia on LinkedIn and X.
© Copyright 2026. Proscia Inc., Proscia, Concentriq, Proscia Aperture, the circles logo and Proscia Aperture logo are trademarks or registered trademarks owned by Proscia Inc. All rights reserved.
Concentriq AP-Dx is FDA-cleared for primary diagnosis in the United States (U.S.) with the Hamamatsu NanoZoomer® S360MD Slide scanner and is licensed in Canada and CE‑marked under the EU IVDR for primary diagnosis. Concentriq AP-Dx is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens. Concentriq AP and Concentriq LS are for Research Use Only. Not for use in diagnostic procedures.